These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Synchronous carcinoma of the gallbladder in a patient with intrahepatic bile duct carcinoma. Taniai N; Onda M; Tajiri T; Yoshida H; Naitou Z Hepatogastroenterology; 2000; 47(31):121-4. PubMed ID: 10690592 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969 [TBL] [Abstract][Full Text] [Related]
26. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890 [TBL] [Abstract][Full Text] [Related]
29. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285 [TBL] [Abstract][Full Text] [Related]
30. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones". Hunt JP; Varnholt H Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649 [No Abstract] [Full Text] [Related]
31. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case. Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738 [TBL] [Abstract][Full Text] [Related]
32. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. Chen RF; Li ZH; Zou SQ; Chen JS Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924 [TBL] [Abstract][Full Text] [Related]
33. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature. Xu AM; Xian ZH; Zhang SH; Chen XF Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767 [TBL] [Abstract][Full Text] [Related]
34. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. Chang KY; Chang JY; Yen Y J Natl Compr Canc Netw; 2009 Apr; 7(4):423-7. PubMed ID: 19406042 [TBL] [Abstract][Full Text] [Related]